While most glucose-lowering therapies were not significantly associated with a reduction in dementia risk, the GLP-1 drugs were linked to a 45 percent reduction in the risk of Alzheimers disease and other forms of dementia
[DOI] [PubMed] [Google Scholar] 185.Kruh J.N., Kruh-Garcia N.A., Foster C.S
We're giving you 90 days' notice to figure out what you want to do.'" From 2025 to 2026, 12 million people were on plans that dropped coverage for Zepbound and 12 million had plans that dropped Wegovy, another GLP-1, according to research by GoodRx, a website that helps patients find discounts on prescription drugs
Semaglutide vs Tirzepatide for weight loss is a hot topic right nowboth are leading names in the market, but with all the buzz, it can be hard to figure out which one is right for you
If you put it back in the fridge and take it out again, the counter does not reset